Cash‑flow Volatility HistoryHistoric swings in operating and free cash flow create execution and financing uncertainty. While 2025 operating cash improved, prior negative cash generation and year‑to‑year FCF declines indicate the company's cash conversion can be volatile, complicating multi‑year CapEx and working‑capital plans.
Prior High LeverageAlthough leverage has declined in 2025, the company’s recent history of materially higher debt ratios raises refinancing and covenant risk over cycles. Legacy leverage can constrain flexibility during required multi‑year investments and makes sustained deleveraging a necessary priority for durable financial health.
U.S. Concentration & Execution RiskHeavy reliance on U.S. volumes increases customer and policy concentration risk; simultaneous multi‑year capex (module ramp, planned cell plant) concentrates execution and permitting risk. Delays or U.S. policy/audit outcomes (e.g., 45X credits) could materially affect expected cash flows and project economics.